Bulgaria · 
What does Innovation Capital invest in?
Innovation Capital invests most often at Series A and Series B (53% of the rounds on record), in sectors such as Startups.
Innovation Capital highlights
- 01
15 rounds on record
- 02
Mostly Series A and Series B: 53% of its rounds
- 03
1 exits from the portfolio
What they do
- Type
- Accelerator (from a list, unverified)
- Cheque size
- $29K – $1.1M as they say
- Stages
- Pre-seedSeedSeries ASeries B
- Sectors
- Startups
- Based in
- Sofia, Bulgaria
- Cold pitches
- Not accepted
A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.
The record
Every round we can evidence, newest first15 appearances
- 2015
2 rounds
- Jun
- May
- 2009
1 round
- Sept
- 2008
1 round
- Feb
- 2007
1 round
- Dec
- 2006
1 round
- Apr
- 2004
3 rounds
- Nov
- Oct
- Sept
- 2003
3 rounds
- Nov
- May
- Mar
- 2001
1 round
- Mar
- 2000
2 rounds
- Jan
- Jan
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
What they claim to have backed
From their own portfolio page (on their website)
7 of 55 we have independently watched raise
AvtoikonomEconiconeEdamamMaplebearScalaSolarsteamTokwise3dbghubAidesignAqualidArtimeAskthecpAyurvedahealingB-investBulgarian-storiesBum-bamByebyestutteringCardinalbitesCargentaChillandbiteComacoatelierCosheraDalivinoDancinggoatsDermicoDoggocollarE-driveEasydocEcovox-bgEstatepilotEvageneFabricoFastbooksFightscoutGravitalIrisbgsfIvlKrikMetabMrcaseNovatiospaceNuinsPaggasPaw2pawPleggiPricemindRebenefitSappienceShareascootShimaniThemeatboxUbitrackVavakadaWhisphealthYox
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Santaris PharmaBought by Roche$450MAug 2014
An exit counts when it came after the firm's first round in the company. From historical deal records.